Topical evening primrose oil for reduction of bortezomib-induced skin reactions

Ann Hematol. 2013 Jul;92(7):995-6. doi: 10.1007/s00277-012-1656-2. Epub 2012 Dec 22.
No abstract available

Publication types

  • Letter

MeSH terms

  • Administration, Cutaneous
  • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Boronic Acids / administration & dosage
  • Boronic Acids / adverse effects*
  • Bortezomib
  • Drug Eruptions / drug therapy*
  • Drug Eruptions / etiology
  • Drug Evaluation
  • Humans
  • Injections, Subcutaneous
  • Linoleic Acids / administration & dosage
  • Linoleic Acids / therapeutic use*
  • Oenothera biennis
  • Phytotherapy*
  • Plant Oils / administration & dosage
  • Plant Oils / therapeutic use*
  • Protease Inhibitors / administration & dosage
  • Protease Inhibitors / adverse effects*
  • Pyrazines / administration & dosage
  • Pyrazines / adverse effects*
  • gamma-Linolenic Acid / administration & dosage
  • gamma-Linolenic Acid / therapeutic use*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Boronic Acids
  • Linoleic Acids
  • Plant Oils
  • Protease Inhibitors
  • Pyrazines
  • evening primrose oil
  • Bortezomib
  • gamma-Linolenic Acid